Literature DB >> 30822095

New Applications of Old Drugs as Novel Therapies in Idiopathic Pulmonary Fibrosis. Metformin, Hydroxychloroquine, and Thyroid Hormone.

Edward P Manning1, Ashley Losier1, Nkiruka Emeagwali1, Changwan Ryu1, Shyoko Honiden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30822095      PMCID： PMC7051474          DOI： 10.1164/rccm.201809-1700RR

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  24 in total

1.  PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis.

Authors:  Marta Bueno; Yen-Chun Lai; Yair Romero; Judith Brands; Claudette M St Croix; Christelle Kamga; Catherine Corey; Jose D Herazo-Maya; John Sembrat; Janet S Lee; Steve R Duncan; Mauricio Rojas; Sruti Shiva; Charleen T Chu; Ana L Mora
Journal:  J Clin Invest       Date:  2014-12-22       Impact factor: 14.808

Review 2.  Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.

Authors:  Wilmar M Wiersinga
Journal:  Nat Rev Endocrinol       Date:  2014-01-14       Impact factor: 43.330

Review 3.  Therapeutic targets in idiopathic pulmonary fibrosis.

Authors:  Martin Kolb; Francesco Bonella; Lutz Wollin
Journal:  Respir Med       Date:  2017-08-01       Impact factor: 3.415

4.  Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.

Authors:  Ganesh Raghu; Bernt van den Blink; Mark J Hamblin; A Whitney Brown; Jeffrey A Golden; Lawrence A Ho; Marlies S Wijsenbeek; Martina Vasakova; Alberto Pesci; Danielle E Antin-Ozerkis; Keith C Meyer; Michael Kreuter; Hugues Santin-Janin; Geert-Jan Mulder; Brian Bartholmai; Renu Gupta; Luca Richeldi
Journal:  JAMA       Date:  2018-06-12       Impact factor: 56.272

Review 5.  An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy.

Authors:  Geoffrey Kurland; Robin R Deterding; James S Hagood; Lisa R Young; Alan S Brody; Robert G Castile; Sharon Dell; Leland L Fan; Aaron Hamvas; Bettina C Hilman; Claire Langston; Lawrence M Nogee; Gregory J Redding
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

Review 6.  Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases.

Authors:  Sarah Braun; Marion Ferner; Kai Kronfeld; Matthias Griese
Journal:  Pediatr Pulmonol       Date:  2014-12-09

7.  Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland.

Authors:  R Dinwiddie; N Sharief; O Crawford
Journal:  Pediatr Pulmonol       Date:  2002-07

8.  Pirfenidone treatment of idiopathic pulmonary fibrosis.

Authors:  Ye Gan; Erica L Herzog; Richard H Gomer
Journal:  Ther Clin Risk Manag       Date:  2011-02-08       Impact factor: 2.423

9.  Cholesterol-modified Hydroxychloroquine-loaded Nanocarriers in Bleomycin-induced Pulmonary Fibrosis.

Authors:  Li Liu; Jun Ren; Zhiyao He; Ke Men; Ye Mao; Tinghong Ye; Hua Chen; Ling Li; Bocheng Xu; Yuquan Wei; Xiawei Wei
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

Review 10.  Hydroxychloroquine: from malaria to autoimmunity.

Authors:  Ilan Ben-Zvi; Shaye Kivity; Pnina Langevitz; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667
View more
  2 in total

1.  Effectiveness and mechanism of metformin in animal models of pulmonary fibrosis: A preclinical systematic review and meta-analysis.

Authors:  Xuanyu Wu; Xiang Xiao; Xinyu Chen; Maoyi Yang; Zhipeng Hu; Sijia Shuai; Qinwei Fu; Han Yang; Quanyu Du
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

2.  Idiopathic pulmonary fibrosis and diabetes mellitus: a meta-analysis and systematic review.

Authors:  Le Bai; Li Zhang; Tingyu Pan; Wei Wang; Dian Wang; Cassidy Turner; Xianmei Zhou; Hailang He
Journal:  Respir Res       Date:  2021-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.